Al-Dirbashi O Y, Shaheen R, Al-Sayed M, Al-Dosari M, Makhseed N, Abu Safieh L, Santa T, Meyer B F, Shimozawa N, Alkuraya F S
National Laboratory for Newborn Screening, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Am J Med Genet A. 2009 Jun;149A(6):1219-23. doi: 10.1002/ajmg.a.32874.
Peroxisomal biogenesis disorders represent a group of genetically heterogeneous conditions that have in common failure of proper peroxisomal assembly. Clinically, they are characterized by a spectrum of dysmorphia, neurological, liver, and other organ involvement. To date, mutations in 13 PEX genes encoding peroxins have been identified in patients with peroxisomal biogenesis disorders. Mutations in PEX13, which encodes peroxisomal membrane protein PEX13, are among the least common causes of peroxisomal biogenesis disorders with only three mutations reported so far. Here, we report on two infants whose clinical and biochemical profile was consistent with classical Zellweger syndrome and whose complementation analysis assigned them both to group H of peroxisomal biogenesis disorders. We show that they harbor two novel mutations in PEX13. One patient had a genomic rearrangement resulting in a 147 kb deletion that spans the whole of PEX13, while the other had an out-of-frame deletion of 14 bp. This represents the first report of a PEX13 deletion and suggests that further work is needed to examine the frequency of PEX13 mutations among Arab patients with peroxisomal biogenesis disorders.
过氧化物酶体生物发生障碍是一组基因异质性疾病,其共同特征是过氧化物酶体无法正常组装。临床上,它们的特点是出现一系列畸形、神经、肝脏和其他器官受累的症状。迄今为止,在过氧化物酶体生物发生障碍患者中已鉴定出13个编码过氧化物酶的PEX基因突变。编码过氧化物酶体膜蛋白PEX13的PEX13基因突变是过氧化物酶体生物发生障碍最不常见的原因之一,迄今为止仅报道了3种突变。在此,我们报告了两名婴儿,他们的临床和生化特征与经典的泽尔韦格综合征一致,并且通过互补分析将他们都归类为过氧化物酶体生物发生障碍的H组。我们发现他们在PEX13中存在两个新的突变。一名患者发生了基因组重排,导致147 kb的缺失,该缺失跨越了整个PEX13基因,而另一名患者发生了14 bp的移码缺失。这是关于PEX13缺失的首次报道,并表明需要进一步开展工作来研究阿拉伯过氧化物酶体生物发生障碍患者中PEX13突变的频率。